Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;202(3):1067-1083.
doi: 10.1007/s12011-023-03742-9. Epub 2023 Jul 7.

Protective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Adult Male Albino Rats: Histological and Immunohistochemical Study

Affiliations

Protective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Adult Male Albino Rats: Histological and Immunohistochemical Study

Melad N Kelada et al. Biol Trace Elem Res. 2024 Mar.

Abstract

Cisplatin is a potent antineoplastic drug that is used for treatment of many solid tumors. It has a wide range of adverse effects. Nephrotoxicity is the most common one of them. Platelet-rich plasma (PRP) is an autologous human plasma that activates the tissue regeneration through cell proliferation and differentiation. Study the role of PRP in amelioration of cisplatin-induced nephrotoxicity on the kidney of adult male albino rats by biochemical, morphometric, histological, and immunohistochemical studies. Thirty-five adult male albino rats were used. Thirty rats were included as experimental group and five were used to obtain the PRP. The experimental group was classified into as follows: control group which received 1mL of sterile saline by intraperitoneal injection (IP), cisplatin-treated group which received cisplatin 7.5 mg/kg IP in a single dose and cisplatin and PRP-treated group rats received cisplatin 7.5 mg/kg single IP dose followed by 1ml of PRP IP after 24 h of cisplatin injection. There was a significant increase in urea and creatinine levels in cisplatin-treated group in comparison to the control and the PRP groups. The kidneys of cisplatin-treated group showed distorted renal structure, where specimens of PRP-treated group revealed restoration of the classical appearance of the renal tissue similar to the control group. PRP has protective effects on renal structure and functions and it helps to ameliorate the histological changes induced by cisplatin.

Keywords: Cisplatin; Drug-induced nephrotoxicity; Immunohistochemistry; Morphometric parameters; PRP.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Light photomicrographs of rat’s kidney control group showing a renal cortex arranged into cortical labyrinths and medullary rays. It shows normal appearance of the renal corpuscle (RC), proximal convoluted tubules (PT), and distal convoluted tubules (DT). b Higher magnification showing the Bowman’s space of the renal corpuscle ( formula image ). Proximal convoluted tubules showing prominent brush border ( formula image ). The distal convoluted tubules (DT) appear with wider lumen and cuboidal cells with rounded nuclei. c The medulla is seen occupied by medullary rays (MR), collecting ducts (CD), renal interstitium ( formula image ), and blood vessels ( formula image ). (H&E. Mic.Mag a ×100, b ×400, and c ×100)
Fig. 2
Fig. 2
Light photomicrographs of a section of renal cortex from cisplatin-treated group showing a the cortex with distorted renal corpuscles (RC), ballooning of the tubules of the medullary rays (MR), intense cellular infiltration ( formula image ) among the degenerated tubules ( formula image ), and focal areas of proximal tubules with acidophilic cytoplasm (PT). b The medulla shows distorted tubules with multiple hyaline casts within their lumina ( formula image ). Some of the tubules appears dilated (T), and others show obliterated lumen ( formula image ). c The renal corpuscles (RC) appear with shrunken glomerular tuft and pyknotic nuclei ( formula image ). Peritubular cellular infiltration is noticed around the distorted tubules ( formula image ). The proximal convoluted tubules show vaculations ( formula image ), bizzare shaped nuclei of the lining cells ( formula image ), and extruded cells in the lumen with loss of brush border and basophilic cytoplasm ( formula image ). Distorted distal convoluted tubules with flattened cells are seen (DT). d The proximal tubules (PT) show karyolitic nuclei ( formula image ). Some tubules (T) show hyaline casts and exfoliated cells within their lumina ( formula image ). There are peritubular cellular infiltration ( formula image ) and proliferating interstitial fibroblasts ( formula image ). e Renal corpuscle (RC) appears with shrunken glomerular tuft and dark nuclei. Many tubules show severe ballooning (T). Cells of proximal convoluted tubules show vaculations with loss of brush boarder (PT). (H&E. Mic.Mag a, b ×100, ce ×400)
Fig. 3
Fig. 3
Light photomicrographs of rat’s kidney from cisplatin and PRP-treated group showing a, b the renal corpuscles appear nearly normal with bifurcated glomerular tuft (RC), many normal proximal convoluted tubules with eosinophilic cytoplasm and intact epithelial lining (PT). Few tubules are obliterated, with basophilic cytoplasm ( formula image ), and others appeared degenerated with hyalinized material in their lumen ( formula image ). b Distal convoluted tubules appear with cuboidal epithelial lining (DT). Widened interstitial space with evident cellular infiltration ( formula image ) and extravasated RBCs (RBCs) are also seen ( formula image ); brush border of PCT. (H&E. Mic.Mag a ×100 and b ×400)
Fig. 4
Fig. 4
Light photomicrographs of the renal cortex of the control group showing a normal distribution of the collagen fibers in the mesangium of the renal corpuscle ( formula image ). b The medulla shows some collagen fibers in the peritubular interstitium ( formula image ). (Massonʼs trichrome. Mic.Mag a ×400 and b ×100)
Fig. 5
Fig. 5
Light photomicrographs of renal cortex from the cisplatin-treated group showing a intense collagen fiber deposition in the cortical peritubular interstitium ( formula image ) and in the mesangium of the renal corpuscle ( formula image ). Some distal tubules show dilatation (DT). b Intense collagen fiber deposition in the medullary interstitium ( formula image ). Some tubules show hyaline casts deposition ( formula image ). (Massonʼs trichrome. Mic.Mag a ×400 and b ×100)
Fig. 6
Fig. 6
Light photomicrographs of renal cortex from cisplatin and PRP-treated group showing a mild collagen fibers deposition in the mesangium of the renal corpuscles ( formula image ) and peritubular interstitium ( formula image ). Some proximal tubules are normal (PT), whereas others are abnormal with prominent vaculations ( formula image ). Some of the distal tubules are dilated (DT). b Moderate collagen fiber deposition in the medullary interstitium ( formula image ). Some tubules show hyaline cast deposition ( formula image ). There are vasa recta and extravasated RBCs in between the parallel tubules ( formula image ). (Masson trichrome. Mic.Mag a ×400 and b ×100)
Fig. 7
Fig. 7
Light photomicrographs of renal cortex revealing a control group illustrates positive PAS reaction in the glomerulus, the basement membrane of the renal tubules ( formula image ), and brush border of proximal convoluted tubules ( formula image ). It is stained magenta red with the PAS stain. b The cisplatin-treated group shows thickened basement membrane of the glomerular tuft ( formula image ). One of the glomeruli shows hyper cellularity (RC). Many proximal convoluted tubules appear degenerated with thickened basement membrane around them ( formula image ). Some tubules show hyaline casts within its lumen ( formula image ). Some distal tubules show dilatation (DT). c Cisplatin and PRP-treated group shows positive reaction within the basement membrane of the renal corpuscle and the proximal convoluted tubules ( formula image ). Few of them appear degenerated with thickened basement membrane ( formula image ). Some distal tubules show dilatation with thickened epithelial basement membrane (DT), and others appear nearly normal (PAS. Mic.Mag ×400)
Fig. 8
Fig. 8
Light photomicrographs of section of the renal cortex: a the control group shows weak immunohistochemical reaction within the cells of the distal renal tubules ( formula image ) and the interstitium ( formula image ). b Cisplatin-treated group shows intense positive reaction in the degenerated tubules with obliterated lumen ( formula image ). The interstitium shows strong positive reaction ( formula image ). Also, there is strong positive reaction within the cells of the glomerular capillary tuft ( formula image ) of the renal corpuscle (RC). c Cisplatin and PRP-treated group shows positive reaction within the lining cells of some tubules (T), and others show weak reaction ( formula image ). Few cells of the glomerular tuft show positive reaction ( formula image ) (caspase-3 immunohistochemical staining. Mic.Mag ×400)

Similar articles

Cited by

References

    1. Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci. 2019;20(12):3011. doi: 10.3390/ijms20123011. - DOI - PMC - PubMed
    1. Gold J, A. R. Cisplatin. StatPearls Publishing: StatPearls Publishing; 2020.
    1. Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, et al. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951–1969. doi: 10.1038/s41401-021-00620-9. - DOI - PMC - PubMed
    1. Laplace N, Kepenekian V, Friggeri A, Vassal O, Ranchon F, Rioufol C, et al. Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin. Int J Hyperthermia. 2020;37(1):897–902. doi: 10.1080/02656736.2020.1795277. - DOI - PubMed
    1. Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–634. doi: 10.1007/s12178-018-9527-7. - DOI - PMC - PubMed